CNS Pharmaceuticals (CNSP) Free Cash Flow (2018 - 2025)
CNS Pharmaceuticals' (CNSP) quarterly Free Cash Flow came in at -$3.1 million in Q4 2025, up 44.26% YoY from -$2.1 million in Q4 2024, and down 40.36% on a QoQ basis from -$2.2 million in Q3 2025.
CNS Pharmaceuticals (CNSP) Free Cash Flow (2018 - 2025) Analysis & Trends
CNS Pharmaceuticals (CNSP) has 8 years of Free Cash Flow data on file, last reported at -$3.1 million in Q4 2025.
- Quarterly Free Cash Flow rose 44.26% year-over-year to -$3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$13.8 million (up 19.32% YoY) and the FY2025 annual result came in at -$13.8 million, up 19.21% from the prior year.
- Free Cash Flow slipped to -$3.1 million in Q4 2025, from -$2.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.7 million in Q2 2024 to a low of -$6.8 million in Q3 2024.
- A 5-year average of -$3.5 million and a median of -$3.2 million in 2021 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 68.03% in 2025, down 223.76% in 2025.
- Tracing CNSP's Free Cash Flow over 5 years: stood at -$3.2 million in 2021, then grew by 28.82% to -$2.3 million in 2022, then slipped by 10.12% to -$2.5 million in 2023, then slumped by 115.68% to -$5.5 million in 2024, then jumped by 44.26% to -$3.1 million in 2025.
- The last three Free Cash Flow figures came in at -$3.1 million (Q4 2025), -$2.2 million (Q3 2025), and -$5.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | CNS Pharmaceuticals | 2.65 Mn | -4.55 Mn | - | -3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.05 Mn |
| Dec 31, 2025 | -3.05 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Mar 31, 2025 | -3.24 Mn |
| Mar 31, 2025 | -3.24 Mn |
| Dec 31, 2024 | -5.48 Mn |
| Dec 31, 2024 | -5.48 Mn |
| Sep 30, 2024 | -6.80 Mn |
| Sep 30, 2024 | -6.80 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | -3.19 Mn |
| Mar 31, 2024 | -3.19 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Sep 30, 2023 | -3.38 Mn |
| Sep 30, 2023 | -3.38 Mn |